Stanford Cancer Institute Directory
Showing 261 - 270 of 460
Professor of Biomedical Data Science and, by courtesy, of Radiology (Molecular Imaging) and of Health Research and Policy (Epidemiology)
Assistant Professor of Radiology (Pediatric Radiology) at the Stanford University Medical Center
Ann and Bill Swindells Professor in the School of Humanities and Sciences and Professor, by courtesy, of Neurobiology
Dr. Luo grew up in Shanghai, China, and earned his bachelor's degree in molecular biology from the University of Science and Technology of China. After obtaining his PhD in Brandeis University, and postdoctoral training at the University of California, San Francisco, Dr. Luo started his own lab in the Department of Biology, Stanford University in December 1996. Together with his postdoctoral fellows and graduate students, Dr. Luo studies the logic of brain wiring using genetic tools. They have developed mosaic marking systems in flies and mice and used them to study how signals are transduced from cell surface receptors to the cytoskeleton, how neuronal processes are pruned, and how neural circuits are organized and built. Dr. Luo is currently a Professor of Biology and an investigator of the Howard Hughes Medical Institute. He teaches neurobiology to Stanford undergraduate and graduate students. He recently published a single-author textbook entitled “Principles of Neurobiology.” Dr. Luo has served on the editorial boards of several scientific journals, including Neuron, eLife, and Annual Review of Neuroscience. He has also served on the Pew Scholar National Committee and Scientific Advisory Committee of Damon Runyon Cancer Research Foundation. He is recipient of the McKnight Technological Innovation in Neuroscience Award, the Society for Neuroscience Young Investigator Award, the Jacob Javits Award from National Institute of Neurological Disorders and Stroke, HW Mossman Award from American Association of Anatomists, and the Lawrence Katz Prize. Dr. Luo is a Member of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences.
Professor of Pediatrics (Hematology/Oncology) and of Medicine
Crystal L Mackall MD is Endowed Professor of Pediatrics and Internal Medicine at Stanford University. She serves as Founding Director of the Stanford Center for Cancer Cell Therapy, Associate Director of Stanford Cancer Institute, Leader of the Cancer Immunology and Immunotherapy Program at Stanford and Director of the Parker Institute for Cancer Immunotherapy at Stanford. During her tenure as Head of the Immunology Section and Chief of the Pediatric Oncology Branch, NCI, she built an internationally recognized translational research program spanning basic studies of T cell homeostasis and tumor immunology, and clinical trials of immune based therapies for cancer. Her work is credited with identifying an essential role for the thymus in human T cell regeneration and discovering IL-7 as the master regulator of T cell homeostasis. She has led numerous cutting edge and first-in-human and first-in-child clinical trials spanning dendritic cell vaccines, cytokines, and adoptive immunotherapy using NK cells and genetically modified T cells. Her group was among the first to demonstrate impressive activity of CD19-CAR in pediatric leukemia and recently demonstrated impressive activity of a second CAR targeting CD22.. Dr. Mackall’s clinical trials are notable for the incorporation of deep biologic endpoints that further our understanding of the basis for success and failure of the agent under study. She has published over 175 manuscripts and serves in numerous leadership positions, including Leader of the NCI Pediatric Cancer Immunotherapy Trials Network, co-Leader of the St. Baldrick’s-StandUp2Cancer Pediatric Dream Team. She is Board Certified in Pediatrics and Internal Medicine.
Redlich Professor and Professor, by courtesy, of Neurology at the Stanford University Medical Center
Sean Mackey, M.D., Ph.D, is Chief of the Division of Pain Medicine and Redlich Professor of Anesthesiology, Perioperative and Pain Medicine, Neurosciences and Neurology at Stanford University. He is the Immediate Past President of the American Academy of Pain Medicine. Dr. Mackey received his BSE and MSE in Bioengineering from University of Pennsylvania and his PhD in Electrical and Computer Engineering as well as MD from University of Arizona. Dr. Mackey is author of over 200 journal articles, book chapters, abstracts, and popular press pieces in addition to numerous national and international lectures. Under Dr. Mackey’s leadership, the Stanford Pain Management Center has been designated a Center of Excellence by the American Pain Society, one of only two centers to receive this honor twice. In 2011 he was a member of the Institutes of Medicine committee that issued the report on Relieving Pain in America. He is currently Co-Chair of the Oversight Committee for the NIH/Health and Human Services National Pain Strategy, an effort to establish a national health strategy for pain care, education and research. Under Dr. Sean Mackey’s leadership, researchers at the Stanford Pain Management Center and the Stanford Systems Neuroscience and Pain Laboratory (SNAPL) have made major advances in the understanding of chronic pain as a disease in its own right, one that fundamentally alters the nervous system. Dr. Mackey has overseen efforts to map the specific brain and spinal cord regions that perceive and process pain, which has led to the development of a multidisciplinary treatment model that translates basic science research into innovative therapies to provide more effective, personalized treatments for patients with chronic pain.
Associate Professor of Medicine (Hematology)
Dr. Ravi Majeti is an Associate Professor in the Department of Medicine, Chief of the Division of Hematology, and Member of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. He was an undergraduate at Harvard, earned his MD and PhD from UCSF, and trained in Internal Medicine at Brigham and Women’s Hospital in Boston. Dr. Majeti completed his Hematology Fellowship at Stanford, and is a board-certified hematologist. While at Stanford, he completed post-doctoral training in the laboratory of Irving Weissman, where he investigated acute myeloid leukemia (AML) stem cells and therapeutic targeting with anti-CD47 antibodies. With Dr. Weissman, he developed a humanized anti-CD47 antibody, initiated first-in-human clinical trials, and in 2015, co-founded Forty Seven Inc. Dr. Majeti established his independent laboratory in 2009 with research focused on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly AML. Dr. Majeti is a recipient of the Burroughs Wellcome Fund Career Award for Medical Scientists, the New York Stem Cell Foundation Robertson Investigator Award, and the Leukemia and Lymphoma Society Scholar Award.